✦ LIBER ✦

1017 Reexamining the role of prostate specific antigen density in predicting outcome for clinically localized prostate cancer

✍ Scribed by Anthony C. Ingenito; Ronald D. Ennis; I-Chow Hsu; Melissa Begg; Mitchell C. Benson; Peter B. Schiff

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 89 KB
Volume: 32
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(95)97842-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The impact of a delay in initiating radi

The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

✍ Paul L. Nguyen; Richard Whittington; Sophia Koo; Delray Schultz; Kerri B. Cote; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Linear regressive analysis using prostat

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

✍ Anthony V. D'amico; Gerald E. Hanks 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Background. This study was undertaken to calculate the prostate-specific antigen doubling time (PSA-DT) of prostate cancers recurrent after external beam radiation therapy and to investigate if a correlation exists between the PSA-DT and the clinical behavior of prostate cancer as a possible reflect

Predicting the risk of lymph node involv

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancer

✍ Mack Roach III; Carol Marquez; Hae-Sook Yuo; Perinchery Narayan; Lorie Coleman; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Prognostic factors for clinically locali

Prognostic factors for clinically localized prostate carcinoma : Analysis of 938 patients irradiated in the prostate specific antigen era

✍ Gunar K. Zagars; Alan Pollack; Andrew C. von Eschenbach 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

The Uniirradiated in the PSA era. versity of Texas, M. D. Anderson Cancer Center, ## METHODS. The authors analyzed the outcome for a group of 938 men with T1-T4,

Biochemical outcome after radical prosta

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

✍ Anthony V. D'Amico; Richard Whittington; S. Bruce Malkowicz; Kerri Cote; Marian 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## BACKGROUND To the authors' knowledge, consensus is lacking regarding the relative long‐term efficacy of radical prostatectomy (RP) versus conventional‐dose external beam radiation therapy (RT) in the treatment of patients with clinically localized prostate carcinoma. ## METHODS A

The role of digital rectal examination,

The role of digital rectal examination, transrectal ultrasound, and prostate specific antigen for the detection of confined and clinically relevant prostate cancer

✍ Fred Lee; Peter J. Littrup 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

In a study population, can digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA) (monoclonal) effectively detect the majority of clinically relevant cancer? If this is possible, the remaining patients could then be considered for chemopreventive protoco